Radicava Now Available, Offering Real Hope to ALS Patients
This segment from CBS Boston is sharing the good news that the FDA-approved drug Radicava for the treatment of amyotrophic lateral sclerosis (ALS) is now available for patients in the U.S.
The breakthrough drug has been found to slow down the progression of ALS by up to a third in clinical trials in Japan and although best taken when first diagnosed, the drug can be prescribed at any point of the disease.
Radicava offers a real lifeline to people suffering from ALS and their families, as the extended life expectancy means they can spend more time with their loved ones. This is the first drug approved by the FDA for the treatment of ALS in more than two decades.
Every 90 minutes, someone is diagnosed with ALS and someone dies from the disease. Radicava will help to preserve muscle function for longer, allowing patients to continue with their lives for much longer.
ALS News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.